[Carriage of A Allele of Polymorphic Marker G(-238)A of TNF-alfa Gene Is Associated With Unfavorable Prognosis in Patients With Chronic Systolic Heart Failure].
Autor: | Gerasimova ON; 1 Presidential Medical Center of Russia, Moscow, Russia; 2City clinical hospital 51, Moscow, Russia; 3Central State Medical Academy, President Management Department RF, Moscow, Russia; 4Russian Cardiology Research and Production Complex, Moscow, Russia; 5Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia; 6Emanuel Institute of Biochemical Physics of RAS Moscow, Russia., Sigalovich EY; 1 Presidential Medical Center of Russia, Moscow, Russia; 2City clinical hospital 51, Moscow, Russia; 3Central State Medical Academy, President Management Department RF, Moscow, Russia; 4Russian Cardiology Research and Production Complex, Moscow, Russia; 5Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia; 6Emanuel Institute of Biochemical Physics of RAS Moscow, Russia., Dankovtseva EN; 1 Presidential Medical Center of Russia, Moscow, Russia; 2City clinical hospital 51, Moscow, Russia; 3Central State Medical Academy, President Management Department RF, Moscow, Russia; 4Russian Cardiology Research and Production Complex, Moscow, Russia; 5Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia; 6Emanuel Institute of Biochemical Physics of RAS Moscow, Russia., Nakonechnikov SN; 1 Presidential Medical Center of Russia, Moscow, Russia; 2City clinical hospital 51, Moscow, Russia; 3Central State Medical Academy, President Management Department RF, Moscow, Russia; 4Russian Cardiology Research and Production Complex, Moscow, Russia; 5Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia; 6Emanuel Institute of Biochemical Physics of RAS Moscow, Russia., Nikitin AG; 1 Presidential Medical Center of Russia, Moscow, Russia; 2City clinical hospital 51, Moscow, Russia; 3Central State Medical Academy, President Management Department RF, Moscow, Russia; 4Russian Cardiology Research and Production Complex, Moscow, Russia; 5Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia; 6Emanuel Institute of Biochemical Physics of RAS Moscow, Russia., Ivanova ZV; 1 Presidential Medical Center of Russia, Moscow, Russia; 2City clinical hospital 51, Moscow, Russia; 3Central State Medical Academy, President Management Department RF, Moscow, Russia; 4Russian Cardiology Research and Production Complex, Moscow, Russia; 5Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia; 6Emanuel Institute of Biochemical Physics of RAS Moscow, Russia., Masenko VP; 1 Presidential Medical Center of Russia, Moscow, Russia; 2City clinical hospital 51, Moscow, Russia; 3Central State Medical Academy, President Management Department RF, Moscow, Russia; 4Russian Cardiology Research and Production Complex, Moscow, Russia; 5Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia; 6Emanuel Institute of Biochemical Physics of RAS Moscow, Russia., Nosikov VV; 1 Presidential Medical Center of Russia, Moscow, Russia; 2City clinical hospital 51, Moscow, Russia; 3Central State Medical Academy, President Management Department RF, Moscow, Russia; 4Russian Cardiology Research and Production Complex, Moscow, Russia; 5Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia; 6Emanuel Institute of Biochemical Physics of RAS Moscow, Russia., Zateyshchikov DA; 1 Presidential Medical Center of Russia, Moscow, Russia; 2City clinical hospital 51, Moscow, Russia; 3Central State Medical Academy, President Management Department RF, Moscow, Russia; 4Russian Cardiology Research and Production Complex, Moscow, Russia; 5Federal Research Clinical Center for specialized types of health care and medical technologies, Moscow, Russia; 6Emanuel Institute of Biochemical Physics of RAS Moscow, Russia. |
---|---|
Jazyk: | ruština |
Zdroj: | Kardiologiia [Kardiologiia] 2015 Sep; Vol. 55 (9), pp. 25-30. |
Abstrakt: | Aim: to elucidate association between polymorphic markers of interleukin- 6 (Il-6) and tumor necrosis factor (TNF) genes and unfavorable outcomes in patients with chronic heart failure (CHF). Material and Methods: We determined levels of TNF and Il-6 and genotypes of polymorphic markers G(-238)A of TNF gene (rs361525) and G(-174)C of IL-6 gene (rs1800795) in 151 patients (mean age 64.5 years) hospitalized because of decompensation of systolic CHF (left ventricular ejection fraction less or equal 40%) after stabilization of their state. Unfavorable outcomes were registered during follow-up for 2 years. Results: Mean levels of NT-proBNP, Il-6, and TNF were 2481.1+/-199.86 fmol/ml, 21.8+/-7.46 rg/ml, and 10.07+/-0.65 rg/ml, respectively. 138 (94.4%), 13 (8.6%) and 0 patients were carriers of genotypes GG, AG, and AA of polymorphic marker G(-238)A of TNF gene, respectively; 54 (35.8%), 69 (45.7%), and 28 (18.5%) patients carried genotypes GG, GC, and of polymorphic marker G(-174)C gene IL-6, respectively. There was no association between Il-6, TNF levels and carriage of either of genotypes as well as unfavorable clinical course of CHF. Mean survival time before repetitive episode of CHF decompensation (including lethal one) was significantly shorter among carriers of A allele compared with carriers of G allele of polymorphic marker G(-238)A of TNF gene (243+/-97.7 and 947+/-78 days, respectively, =0.018). Mean time before all cause death was also shorter in carriers of A compared with carriers of G allele (289+/-122.9 and 1039+/-73.3 days, respectively, p=0.03). The studied polymorphism of IL-6 gene had no prognostic value. Conclusion: We obtained data on association between carriage of A allele of polymorphic marker G(-238)A of TNF gene and unfavorable prognosis in patients with CHF and inpraired left ventricular systolic function. |
Databáze: | MEDLINE |
Externí odkaz: |